CA Patent

CA2464333C — Heteroindanes: a new class of potent cannabimimetic ligands

Assigned to University of Connecticut · Expires 2011-07-26 · 15y expired

What this patent protects

One aspect of the invention is concerned with cannabimimetic heteroindane analogs having affinities and/or selectivities for a cannabinoid receptor. A further aspect of the invention is concerned with pharmaceutical preparations employing the inventive analogs and methods of admi…

USPTO Abstract

One aspect of the invention is concerned with cannabimimetic heteroindane analogs having affinities and/or selectivities for a cannabinoid receptor. A further aspect of the invention is concerned with pharmaceutical preparations employing the inventive analogs and methods of administering therapeutically effective amounts of the inventive analogs to provide a physiological effect.

Drugs covered by this patent

Patent Metadata

Patent number
CA2464333C
Jurisdiction
CA
Classification
—
Expires
2011-07-26
Drug substance claim
No
Drug product claim
No
Assignee
University of Connecticut
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.